BreastArchives
Breast cancer patients' experiences and outcomes of mainstream genetic testing with and without genetic counseling
Breast 1 min.
As demand for breast cancer germline testing has increased, mainstream genetic testing models of care have been implemented to increase access to genetic testing. This study examined patients' experiences of mainstream genetic testing and compared outcomes between patients seen only by their breast specialist...
Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication
Breast 1 min.
This study explored perceptions and initial experiences of abemaciclib, a CDK4/6 inhibitor, plus endocrine therapy (ET) as adjuvant targeted therapy for early breast cancer with high risk of recurrence (EBC). Early onset diarrhea is the most common side-effect, but its impact is often under-recognized...
Highlights of the San Antonio breast cancer symposium 2025 (Part 2)
Breast 1 min.
The annual San Antonio Breast Cancer Symposium (SABCS) combines the principles of multidisciplinary management, with the basic science underlying pathobiological processes in breast cancer. The 48th meeting was held at the Henry B Gonzales Convention Center in downtown San Antonio, Texas, United States...
From budget constraints to value-based payment: an incremental cost-effectiveness analysis of sacituzumab tirumotecan for advanced triple-negative breast cancer in China
Breast 1 min.
Robust pharmacoeconomic evidence regarding the long-term affordability of sacituzumab tirumotecan (sac-TMT) in treatment of metastatic triple-negative breast cancer (TNBC) remains lacking. We evaluated the cost-effectiveness of sac-TMT versus chemotherapy for previously treated metastatic TNBC from the...
